Salesforce, Inc. CRM

NYSE · Technology · Software - Application

$180.62

Close on Fri, 20 Nov 2026 · market value $149B

What the price is betting on

Below its record

At $181, the price assumes revenue shrinks about 5.9% a year for five years, from $43.9B to about $33.5B by FY2031. That is less than what analysts expect for the next two years and less than the company's own last three years.

The price assumes−5.9%
Analysts, next two years10%
Last 3 years10%

Revenue growth a year. The price figure comes from a reverse DCF at a 9.8% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than CRM? Check up to 5 of your stocks at once, free, no account.

0$20B$40B$60B$80B$43.9B'23'24'25'26Jul '26'27'28'29'30'31What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$337

Base

$417

Bull

$514

Today $181

  • Bear $337. Cash flow grows 6% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $417. Cash flow grows 10% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $514. Cash flow grows 14% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2027$42.6B$46.3B, on the path
  3. FY2028$40.1B$50.9B, on the path
  4. FY2029$37.8B$55.8B, on the path
  5. FY2030$35.6B$61.4B, on the path
  6. FY2031$33.5B$71.5B, on the path

Each year's revenue at −5.9% growth from $43.9B in the 12 months to July 2026.

At a glance

Technology · Software - Application · listed on NYSE

Revenue, FY2026
$41.5B
Growth, 3 years a year
10%
Cash margin
35%
Net debt
$7.6B
Shares, 3-year change
−4.1%
Dividend yield
1.1%

What other technology prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.